TipRanks
Go Ultimate55% OFF

ANI Pharmaceuticals (BSFA) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

BSFA Analyst Ratings

Strong Buy
8Ratings
6Buy2Hold0Sell
Based on 8 analysts giving stock ratings to ANI Pharmaceuticals in the past 3 months

BSFA Stock 12 Month Forecast

CHF 86.92▲(0.00% Upside)
Based on 8 Wall Street analysts offering 12 month price targets for ANI Pharmaceuticals in the last 3 months. The average price target is CHF 86.92 with a high forecast of CHF 98.53 and a low forecast of CHF 69.21. The average price target represents a ― change from the last price of ―.
Highest Price TargetCHF 98.53Average Price TargetCHF 86.92Lowest Price TargetCHF 69.21

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for CH:BSFA
Price TargetFollowArticle
J.P. MorganCHF 93.64buy―Reiterated10/22/26
GuggenheimCHF 96.90buy―Reiterated10/05/26
OppenheimerCHF 69.21hold―Initiated09/23/26
H.C. WainwrightCHF 98.53buy―Reiterated09/21/26
Leerink PartnersCHF 84.68buy―Initiated09/09/26
BarclaysCHF 81.43buy―Reiterated08/25/26
Canaccord GenuityCHF 74.10→CHF 73.28hold―Reiterated08/10/26
Jefferies Analyst forecast on CH:BSFAUnknown AnalystNot RankedJefferiesCHF 97.71buy―Reiterated08/10/26
Piper SandlerCHF 90.38buy―Reiterated04/23/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AXGNAxoGen
SLDBSolid Biosciences
AHCOAdaptHealth
ONCBeOne Medicines
ARDXArdelyx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering ANI Pharmaceuticals

3 Months
Success Rate7/9 ratings generated profit
78%
Average Return
+15.36%

Copying Faisal Khurshid's trades and holding each position for 3 Months would result in 77.78% of your transactions generating a profit, with an average return of +15.36% per trade.

1 Year
Success Rate7/9 ratings generated profit
78%
Average Return
+19.64%

Copying Faisal Khurshid's trades and holding each position for 1 Year would result in 77.78% of your transactions generating a profit, with an average return of +19.64% per trade.

2 Years
Success Rate7/9 ratings generated profit
78%
Average Return
+9.97%

Copying Faisal Khurshid's trades and holding each position for 2 Years would result in 77.78% of your transactions generating a profit, with an average return of +9.97% per trade.

BSFA Analyst Recommendation Trends

05101520Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for BSFA
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy25673
Buy54531
Hold22321
Sell00000
Strong Sell00000
total91114125

In the current month, BSFA has received 4 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. BSFA average Analyst price target in the past 3 months is 86.92.

BSFA Financial Forecast

CHF 0CHF 0.75CHF 1.5CHF 2.25CHF 3Q1 2026Q3 2026Q4 2026
HighCHF 2.42
ConsensusCHF 2.30
LowCHF 2.09

BSFA Earnings Forecast

Next quarter’s earnings estimate for BSFA is CHF 2.30 with a range of CHF 2.09 to CHF 2.42. The previous quarter’s EPS was CHF 2.20. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

CHF 193.4MCHF 211.1MCHF 228.8MCHF 246.5MCHF 264.2MQ1 2026Q3 2026Q4 2026
HighCHF 264M
ConsensusCHF 260M
LowCHF 254M

BSFA Sales Forecast

Next quarter’s sales forecast for BSFA is CHF 260.18M with a range of CHF 253.72M to CHF 264.17M. The previous quarter’s sales results were CHF 236.79M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

BSFA Stock Forecast FAQ

What is CH:BSFA’s average 12-month price target, according to analysts?
Based on analyst ratings, ANI Pharmaceuticals’s 12-month average price target is CHF86.92.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ANI Pharmaceuticals a Buy, Sell or Hold?
ANI Pharmaceuticals has a consensus rating of Strong Buy, which is based on 6 buy ratings, 2 hold ratings and 0 sell ratings.
What is ANI Pharmaceuticals’s share price target?
The average share price target for ANI Pharmaceuticals is CHF86.92. This is based on 8 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF98.53, and the lowest forecast is CHF69.21. The average share price target represents a 0.00% increase from the current price of ―.
What do analysts say about ANI Pharmaceuticals?
ANI Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Street analysts.
How can I buy shares of ANI Pharmaceuticals?
To buy shares of CH:BSFA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.